These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3079095)

  • 1. Peripheral blood chemiluminescence as an early indicator of successful bone marrow transplantation.
    Toivanen A; Nikoskelainen J; Lilius EM; Salmi TT; Kätkä K; Pelliniemi TT; Mäki AL; Rajamäki A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2745-6. PubMed ID: 3079095
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA-DP matching in allogeneic bone marrow transplantation.
    Pawelec G; Ehninger G; Schmidt H; Rehbein A; Balko I; Wernet P
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2741-3. PubMed ID: 3274584
    [No Abstract]   [Full Text] [Related]  

  • 3. An introduction to bone marrow transplantation. Leukemia and aplastic disease--new solutions for old problems.
    Conrad ME
    Ala J Med Sci; 1981 Jul; 18(3):231-2. PubMed ID: 7025678
    [No Abstract]   [Full Text] [Related]  

  • 4. Donors other than HLA-identical siblings.
    Buckner CD; Sanders JE; Anasetti C; Beatty P; Hansen JA; Storb R; Clift R; Thomas ED
    Prog Clin Biol Res; 1989; 309():383-90. PubMed ID: 2675107
    [No Abstract]   [Full Text] [Related]  

  • 5. Herpes virus immunity and acute graft-versus-host disease.
    Gratama JW; Weiland HT; Hekker AC; Weijers TF; The TH; Stijnen T; Zwaan FE; Vossen JM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2680-2. PubMed ID: 2856285
    [No Abstract]   [Full Text] [Related]  

  • 6. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
    Slavin S; Or R; Naparstek E; Weiss L; Mumcuoglu M; Weshler Z; Brautbar H; Cividalli G; Glikson M; Hale G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2614-5. PubMed ID: 3274569
    [No Abstract]   [Full Text] [Related]  

  • 9. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience.
    Buchholz S; Dammann E; Koenecke Ch; Stadler M; Franzke A; Blasczyk R; Bremer M; Krauter J; Hertenstein B; Ganser A; Eder M
    Ann Hematol; 2008 Jul; 87(7):551-6. PubMed ID: 18386010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlations with cyclosporine blood levels after allogeneic bone marrow transplantation: an analysis of four different assays.
    Atkinson K; Downs K; Ashby M; Biggs J
    Transplant Proc; 1990 Jun; 22(3):1331-4. PubMed ID: 2190395
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma exchange for bone marrow transplantation.
    Ho W
    Prog Clin Biol Res; 1982; 88():287-94. PubMed ID: 7048328
    [No Abstract]   [Full Text] [Related]  

  • 12. Transplantation of T lymphocyte depleted bone marrow to prevent graft-versus-host disease: its implications for fetal liver transplantation.
    Champlin RE; Mitsuyasu RT; Gale RP
    Prog Clin Biol Res; 1985; 193():315-25. PubMed ID: 3911215
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for acute graft-versus-host disease in 325 consecutive bone marrow recipients.
    Hägglund H; Boström L; Ringdén O; Nilsson B; Remberger M
    Transplant Proc; 1994 Jun; 26(3):1821-2. PubMed ID: 8030154
    [No Abstract]   [Full Text] [Related]  

  • 15. Importance of bone marrow cell dose in bone marrow transplantation.
    Paulin T
    Clin Transplant; 1992 Feb; 6(1):48-54. PubMed ID: 10150090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation. The state of the art.
    Thomas ED
    Ann Ital Med Int; 1986 Jun; 1(2):109-14. PubMed ID: 3079358
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone marrow transplantation.
    Geary CG; Evans DI; Scarffe JH
    Br J Hosp Med; 1982 Apr; 27(4):393, 395-7, 399. PubMed ID: 7042020
    [No Abstract]   [Full Text] [Related]  

  • 18. Marrow transplantation: the Seattle experience.
    Storb R
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):75-83. PubMed ID: 3914747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone marrow transplantation in childhood. Possibilities and risks].
    Friedrich W; Ebell W
    Monatsschr Kinderheilkd; 1987 May; 135(5):238-44. PubMed ID: 3302683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation for leukaemia: the role of total body irradiation, graft vs host disease, and haemopoietic chimerism.
    Bacigalupo A; Frassoni F; Van Lint MT; Titale V; Scarpati D; Occhini D; Gualandi F; Lamparelli T; Marmont AM
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():85. PubMed ID: 2697412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.